Research programme: dual prostaglandin E2/prostaglandin E4 receptor agonists - SeronoAlternative Names: AS 01; AS 02; Research programme: dual EP2/EP4 receptor agonists - Serono
Latest Information Update: 12 Mar 2008
At a glance
- Originator Merck Serono
- Class Small molecules
- Mechanism of Action Dinoprostone agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 14 Sep 2005 Suspended - Preclinical for Asthma in USA (unspecified route)
- 13 Sep 2004 Preclinical trials in Asthma in USA (unspecified route)